Morgan Joseph TriArtisan Technology Group Advises Green Biologics on $25 Million Growth Equity Financing

  Morgan Joseph TriArtisan Technology Group Advises Green Biologics on $25
  Million Growth Equity Financing

    Sofinnova Partners Led Round that included Strategic Participation By
                   International Conglomerate Swire Pacific

Business Wire

NEW YORK -- December 3, 2013

Morgan Joseph TriArtisan LLC (“MJTA”) announced today that its San
Francisco-based Technology, Media and Telecommunications Investment Banking
Group was exclusive financial advisor to Green Biologics, of Oxford, UK, in
the successful placement of a $25 million Series B round led by Sofinnova
Partners, a global venture capital firm with €1.3 billion under management.

Green Biologics is a leading biochemical company focused on renewable
n-butanol, which represents a $6 billion global market. The financing will
enable the Company to achieve its commercialization efforts, and included
strategic participation from Swire Pacific Limited, a multi-national
conglomerate with ownership interests in various entities including Cathay
Pacific Airways. Existing investors Capricorn Venture Partners, Oxford Capital
Partners, Morningside Ventures, and Convergence Holdings, LLC also
participated in the round.

“Given the global and complex nature of the biochemical industry, we want to
commend Morgan Joseph TriArtisan’s team for its efforts in achieving this
important milestone for the Company.” said Sean Sutcliffe, Green Biologics’
Chief Executive. “The investment brought us new strategic and financial
investors, and positions us well for future growth as we continue to build a
global leader in renewable chemicals.”

Gene Ramirez, Managing Director and head of the MJTA Technology, Media and
Telecommunications Investment Banking Group, commented that “Green Biologics
possesses a leading biochemical platform and has made significant strides in
achieving its technical and commercial milestones. We are pleased to have been
able to secure several highly respected strategic and financial partners for
the Company as they proceed toward full commercial production.”

Gene Ramirez and Matthew McLeod, Vice President, at Morgan Joseph TriArtisan
served as lead advisors on the transaction.

About Morgan Joseph TriArtisan LLC

Morgan Joseph TriArtisan LLC ( is an investment and merchant bank
engaged in providing financial advice, capital raising and private equity
investing. The firm’s services include mergers and acquisitions, in addition
to private placements and public offerings of equity and debt.

About Green Biologics

Green Biologics Ltd. (“GBL”) is a UK-based industrial biotechnology company,
founded in Oxford in 2003 with offices and laboratories in Milton Park in
Abingdon, Oxfordshire. GBL’s US offices are based in Gahanna, Ohio where it
also maintains laboratories and pilot facilities. GBL specializes in the
manufacture of renewable C4 chemicals and advanced biofuels. The company’s
core focus is n-butanol, a backbone chemical used in paints, coatings,
adhesives, inks, plastics, pharmaceuticals, food ingredients, household
cleaners and personal care products with global markets exceeding $6 billion.
GBL has developed advanced fermentation technology to produce renewable
n-butanol from a wide range of feedstocks, including corn and cellulosic
feedstocks such as agricultural and forestry residuals and municipal solid
waste. GBL operates globally in Europe, North America, China, India and
Brazil. For more information, please visit

About Sofinnova Partners

Sofinnova Partners is an independent venture capital firm based in Paris,
France. For more than 40 years, the firm has backed nearly 500 companies at
different stages of their development – pure creations, spin-offs, as well as
turnaround situations – and worked alongside Europe’s key entrepreneurs in the
Life Sciences industry. With €1.3 billion of funds under management, Sofinnova
Partners has created market leaders with its experienced team and hands-on
approach in building portfolio companies through to exit. For more

About Swire

The Swire group was founded in Liverpool in 1816. The group’s interests span
five continents, with principal operations in the Asia Pacific region,
centering on Greater China, with additional major interests in UK, USA, East
Africa, Sri Lanka, Papua New Guinea and Australia. Swire Pacific is one of
Hong Kong's blue chip publicly quoted companies and was formed in 1974 from an
existing publicly listed Swire entity, as the holding company for the Swire
group's principal businesses in Hong Kong, Mainland China, Taiwan, Singapore
and elsewhere. Swire Pacific’s interests are grouped under five divisions:
Property, Aviation, Beverages, Marine Services and Trading & Industrial. The
company is the major shareholder in three other Hong Kong public companies:
Swire Properties, Cathay Pacific Airways and Hong Kong Aircraft Engineering
Company (HAECO). Cathay Pacific and HAECO act as holding companies for Swire
Pacific’s other Aviation Division businesses. Its Industrial interests range
from paint manufacturing to sugar packaging and distribution for historic
brand Taikoo Sugar, established by Swire in 1881.


Steven S. Anreder
Michael Wichman
of Anreder & Company
Press spacebar to pause and continue. Press esc to stop.